Back
Theriva Biologics Stock Price Chart
Sell
34
TOVX
Theriva Biologics
Last Price:
0.37
Seasonality Move:
-6.11%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.39 | Sell |
20-day SMA: | 0.4 | Sell |
50-day SMA: | 0.44 | Sell |
200-day SMA: | 0.48 | Sell |
8-day EMA: | 0.39 | Sell |
20-day EMA: | 0.4 | Sell |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 0.53 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 39.18 | Sell |
Chaikin Money Flow: | -8401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.39 - 0.43) | Sell |
Bollinger Bands (100): | (0.41 - 0.49) | Sell |
Theriva Biologics Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 0.37 while TOVX 8-day simple moving average is 0.39, which is a Sell signal.
- The stock price of TOVX is 0.37 while Theriva Biologics 20-day SMA is 0.40, which makes it a Sell.
- Theriva Biologics 50-day simple moving average is 0.44 while TOVX share price is 0.37, making it a Sell technically.
- TOVX stock price is 0.37 and Theriva Biologics 200-day simple moving average is 0.48, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
34
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Sell
The current Theriva Biologics [TOVX] share price is $0.37. The Score for TOVX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
6.41M
Price in USD:
0.37
Share Volume:
47.61K
Theriva Biologics 52-Week Range
52-Week High:
1.20
52-Week Low:
0.20
Sell
34
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?
The Theriva Biologics stock price is 0.37 USD today. -
Will TOVX stock go up or go down?
Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators -
Is Theriva Biologics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 0.37 while TOVX 8-day exponential moving average is 0.39, which is a Sell signal.
- The stock price of TOVX is 0.37 while Theriva Biologics 20-day EMA is 0.40, which makes it a Sell.
- Theriva Biologics 50-day exponential moving average is 0.43 while TOVX share price is 0.37, making it a Sell technically.
- TOVX stock price is 0.37 and Theriva Biologics 200-day simple moving average is 0.53, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.05 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
- TOVX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Theriva Biologics is a Sell
- Theriva Biologics Relative Strength Index (RSI) is 39.18, which suggest Theriva Biologics is oversold
- The Bollinger Bands (25) for Theriva Biologics is (0.39 - 0.43), which suggest Theriva Biologics is a Sell
- The Bollinger Bands (100) for Theriva Biologics is (0.41 - 0.49), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.